Study examines association of sleep-disordered breathing with Alzheimer’s disease biomarkers

What The Study Did: This study used data and brain imaging from a randomized clinical trial for older adults who are cognitively unimpaired and examined brain changes, including the presence of biomarkers for Alzheimer disease, between those with sleep-disordered breathing and those without.

Authors: Gael Chetelat, Ph.D., of the Universite de Caen in France, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link


Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.


Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time

Media Contact
JAMA Network Media Relations

[email protected]

Copyright © 2021 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0